Nexteligent Holdings Inc (NXGT)

[BIOCHEMUP]

Probably have to wait for next financials to see what’s up here.

[BIOCHEMUP]

Tic Toc. Q4 2022 approaching.

[urge2surge]

Considering the zero credibility they have on failures of executions, they're probably better off on waiting until they actually have a real substantive execution or the RM. 3 transactions generating a 100 million by years end?? Zero communications on updating shareholders for how long now? The only value was in buying up the notes and increasing their restricted percentages. Tight shares bring value, unless they buy a pig in a poke..

[BIOCHEMUP]

Wouldn’t mind some kind of shareholder update PR tho, just to tell the wider context the company is operating in. One could consider that as fluff, the silence could be interpreted in two ways: something is in the works or management doesn’t care. Mystery stock right now, lol.

[urge2surge]

True and still leaning towards a RM. The uplist would be nice but they would need a real catalyst. Don't see it per the last filing. Maybe someday we will all be surprised.

[BIOCHEMUP]

Well nothing happening ain’t necessarily a bad thing. SS still tightly managed.

[urge2surge]

Smoke and mirrors. What's the delay on the RM is my only question. Anything else is just a distraction. Maybe they lost their acquirer? Who knows at this point...

[BIOCHEMUP]

Yeah not even bogus trades (noise) happening. Interesting.

[urge2surge]

No LOI, MOU, 8K, news, and trades. Bring on the RM!

[BIOCHEMUP]

Rockefeller Center, no I’m in Europe. Europoor by political energy market design, lol.

Always had this hunch, an OTC stock with NY Rockefeller center as company adress, smells quite different from your average penny stock. OTCQX and business keen medical acquisitions and we be sitting in dimes.

[Fat Thor]

Anyone here visit rock center this weekend?

[urge2surge]

A lot of good points and agree with the majority. For me, is that worth 5 million in toxic dilution to boot? Solid no here. The financials would have to adjust for the valuation and highly doubt it gets there, let alone accretive. Nothing proprietary as well. Still think the best avenue is the RM. A win on multiple levels.

[BIOCHEMUP]

Services

DME Sales, Marketing, and Billing Services
IMS is contracted with virtually all Private Insurance companies, Medicare (BOC licensed and certified), and Worker’s Compensation providers. Through our network of sales agents, sales representatives, and business alliances; we sell, market, and bill for most physician prescribed orthotic products.

[BIOCHEMUP]

Doesn’t look like a simple middle men reseller of goods judging by the info on their website. Looks like they have a good alliance going on between many stakeholders in the service of medical products.

We work with hospitals, Physician clinics and directly with patients, to provide a comprehensive compliment of DME products. IMS experts is a full service DME provider with over 230 in network private insurance companies, including Medicare (all 4 jurisdictions) and workers comp DME claims. We partner with other medical business distributors and medical DME partners to provide a full line DME products/services to patients across the US.

[BIOCHEMUP]

Lou reads this iHub board by the way. I’m long on this for over a year. I’ll just stick around and see where the ship manoeuvres towards during these economic volatile times. I like your theory about all signals pointing towards a R/M, but honestly we don’t know. Management hasn’t communicated that much this year, especially compared with last year. Now taking the overal OTC market sentiment in consideration, access of seed money for SME is also a big challenge ever since inflation and the war in Ukraine started. Nothing happens in a vacuum so pretty sure these wider macro-economic factors have had some bearing in maneuvering this clean OTC “shell”.

Financials from August still state that they are in business for acquiring SME, so this might contradict your theory on preparing for R/M.

The Nexteligent Executive Team plans to continue executing its acquisition growth strategy with the aim of achieving collective annualized revenues of $100,000,000 through a first phase of acquisitions spanning both small and mid-sized companies.

Hmm IMS Experts, did you check their website again? Looks like a revamped one? https://www.imsexperts.net

[urge2surge]

That would be a good indicator regarding the potential and or viability on an RM. Safe to assume that if authorized is maxed, driving the restricted percentages down, a RM is most likely aborted.

[jump1]

26,062,531 left go time coming….

[urge2surge]

I honestly don't think it will. A search on the business will also get you pics. 5 million for the reseller of non proprietary goods? There's no way that business should get that type of buyout. Beyond ridiculous and a highly questionable transaction IMO. I'll go so far as to say if it does happen, the company committed suicide. Take a look..

[jump1]

100,000,000 is all it is and how much more is their? Out of that amount? I know big payday coming. Have a great weekend.

[BIOCHEMUP]

Lou from IR said they are in due diligence to close the deal though, honestly don’t know what will happen, lol.

[urge2surge]

In it for the RM. Everything else is smoke and mirrors. The acquisition is a joke on many levels or nefarious. It won't happen IMO and it'll be under the safe harbors. That's why the LOI wasn't issued as an official press release, although it does qualify as a material event. Probably got away with that by revealing it in the filing. No S8 either. I gave the reasons why I believe that's their overall intentions. I've still seen nothing to suggest otherwise. You can't be this misspoken, on all matters, for this long, without alternative intentions.

[SpacMan]

Remember when they were going to close 3 deals by end of year.... 2021 lmfao Here we go into Q4 2022. Still 0 deals closed. First deal looks like an absolute turd. No details of how they plan on financing. This is the last management team id bet on. So many tickers to play, why get stuck on this junker? Take a loss and move on if you're still in it.

[urge2surge]

Disregard prior post. For another board.

[urge2surge]

Looks like 5s and lower are coming. Oh well.

[BIOCHEMUP]

Haven’t seen this close at 0.029 for months.

[jump1]

Not just that. Look at the Share structure 100M big bucks return for the patient ones. Not one day of trading last year over 10m in volume. We know it can move 1,000 percent just like that. With this share structure it will all be controlled.

[EmptyBones]

That is why I been accumulating on the bid. The QR report if people would read gives you some big clues..

[urge2surge]

Do some d d and pull up info on the red herring. If you honestly think this dump is worth 5 million, stay on your meds.. A clear sign of inept or malfeasance on management.

[Fat Thor]

It's dogshit...this is a joke. Nobody knows about it. This stock can move to a dollar over a few week period with the right volume.

[BIOCHEMUP]

Just non relevant small volume (noise) between bid and ask?

[Fat Thor]

Na...I've been doing this alotta years. The tape isn't funky. When this goes it's going to go. Seasoned traders are nervous about low float stocks.

Wait for it.

[BIOCHEMUP]

Fact that the Q notified a deal in the making indicates atleast that they are working behind the scenes.

The tape is funky here, jumping between 0.02 and 0.027 on low volume.

[Fat Thor]

Everyone is obsessed about the current "deal" in the Q. What they don't know about the next deal about to be announced. Been along time coming...they are going to deliver IMO.

[EmptyBones]

Looks like deals getting done. Continuous mm shorting soon to get crushed.

[urge2surge]

Scrub the"Deal", it's a red herring. Middle man operation meaning... a re seller of goods. Nothing proprietary. 5 million for selling low margin goods? Give me and the shareholders a break. Scamorama if it happens... As far as tweets, how about building up some grounds on credibility? 100 million in revenue with little to no gas in the tank? Sure....lol

[BIOCHEMUP]

Hi.

As you have stated here, we have executed the APA and are now in Due Diligence to close the deal.

I am sorry, but I am not sure what the reseller middle man is, although I have seen it posted in the chat room,
but can venture to say that this term does not apply.

We will continue to update, as material events occur.

Thank you for being part of NXGT.

Lou S

[BIOCHEMUP]

People close to you? Nothing really moving on the OTC, it’s a sector wide issue. Though, wouldn’t blame them for selling. Nothing substantial happening.

[EmptyBones]

NXGT has a window off opportunity to update share holders in the next few weeks.. If not a few big retail holders will be selling imo.. That will take the stock to 00's

[Fat Thor]

Wait for it for it you momos!! You really think the company controls anything. This fucking thing is going to rocket on the tiny short interest that actually existed still. Lol some dumbass forgot about it. Who knows when…but soon.

[urge2surge]

My take on the filing, and in specific the acquisition therein, is that it will not materialize, which is actually a good thing. They'll get away with it being under the safe harbor act, and probably a LOI or MOU. Either way, it was a red herring. That material event required 3 days to be announced. The RM continues to be the most likely scenario here.

[jump1]

My English writing stinks. Looking for some news soon.

[BIOCHEMUP]

I had to read your post twice before it made any sense lol.

[jump1]

NXGT, will be the talk of the town. This is just a junk stock that traded today, with a huge ballon OS, 0.0221 0.0051 30.00% 265,870,037

WE HAVE 100,000,000 Authorize, $$$ best anywhere. NXGT, insiders are not looking for some cheap return here.
Can’t wait for some beef news.

[BIOCHEMUP]

Not a matter of slow, this stock is still going QX and much we don’t know yet. It’s been a bearish market on the OTC for a year now, many small enterprises suffering in the economic climate post covid with rising prices.

[SpacMan]

Looks like even the slowest ones are starting to catch on here finally.

[BIOCHEMUP]

Mmh maybe I’ll address your concerns about this venue looking like a middle-man business to Sanzaro if we don’t get any follow-up PR in the following days.

Something sounds off with these numbers, that many millions of $. Just weird.

[urge2surge]

So they've updated the filing and now they're clear to reveal news and or developments. On the surface, given the limited amount of info on potentially a new acquisition, we will have to wait on the details. It could be a LOI MOU as well, I'm not ruling that out. The share structures are tight but the financials, as we know are not great. But in fairness, they're better than a lot of OTC. Given the market cap and share structures, I'm still in the RM camp. Why? Because management bought up the notes and increased the restricted. I also believe that the announced buyback of shares has been completed, but they might announce additional shares to buy. Best case imo is the RM. The acquisition in the filing doesn't pass the smell test, and I'd consider it a failure to finalize a RM. I think it would also tell us what type of management is here, not that there hasn't been a clear demonstration of their credibility.
Good luck all

[BIOCHEMUP]

I agree…

[urge2surge]

Nothing proprietary there. Looks like a reseller middleman peddling operation. Board on prescriptive here? Without revenues and ebitda we won't know. Like I said...looks sketchy..

[BIOCHEMUP]

True that’s a big lump sum…